Takeda Pharmaceutical (TAK) Receivables (2017 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Receivables of $5.8 billion for Q2 2026, up 26.89% year-over-year from $4.6 billion in Q2 2025, and up 3.95% quarter-over-quarter from $5.6 billion in Q1 2026.
Takeda Pharmaceutical (TAK) Receivables (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Receivables history runs 10 years deep, the most recent figure standing at $5.8 billion for Q2 2026.
- In Q2 2026, Receivables rose 26.89% year-over-year to $5.8 billion; the TTM figure through Jun 2026 stood at $5.8 billion (up 26.89% YoY), while the FY2026 annual figure was $6.7 billion, up 23.74% from the prior year.
- Receivables for Q2 2026 stood at $5.8 billion, up from $5.6 billion in the prior quarter.
- The five-year high for Receivables was $5.9 billion in Q2 2022, with the low at $347.0 million in Q1 2024.
- The 5-year median for Receivables is $4.8 billion (2023), against an average of $4.4 billion.
- The sharpest annual moves came in 2022 and 2025: Receivables plunged 92.24% in 2022, then soared 1465.92% in 2025.
- Takeda Pharmaceutical's Receivables stood at $5.0 billion in 2022, then dropped by 3.22% to $4.8 billion in 2023, then slipped by 3.42% to $4.7 billion in 2024, then climbed by 2.26% to $4.8 billion in 2025, then climbed by 21.98% to $5.8 billion in 2026.
- Business Quant data shows TAK's Receivables at $5.8 billion in Q2 2026, $5.6 billion in Q1 2026, and $4.8 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.08 Bn |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | 456.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.84 Bn |
| Mar 31, 2026 | 5.62 Bn |
| Dec 31, 2025 | 4.79 Bn |
| Sep 30, 2025 | 4.68 Bn |
| Jun 30, 2025 | 4.60 Bn |
| Mar 31, 2025 | 5.43 Bn |
| Dec 31, 2024 | 4.68 Bn |
| Sep 30, 2024 | 4.70 Bn |
| Jun 30, 2024 | 4.85 Bn |
| Mar 31, 2024 | 346.98 Mn |
| Dec 31, 2023 | 4.85 Bn |
| Sep 30, 2023 | 5.23 Bn |
| Jun 30, 2023 | 5.79 Bn |
| Mar 31, 2023 | 528.97 Mn |
| Dec 31, 2022 | 5.01 Bn |
| Sep 30, 2022 | 5.50 Bn |
| Jun 30, 2022 | 5.89 Bn |
| Mar 31, 2022 | 629.43 Mn |
| Dec 31, 2021 | 6.29 Bn |
| Sep 30, 2021 | 7.66 Bn |